075L3ZZ
Destruction Cisterna Chyli to No Qualifier with No Device, Percutaneous Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | 0 Medical and Surgical |
| Body System | 7 Lymphatic and Hemic Systems |
| Operation | 5 Destruction |
| Body Part | L Cisterna Chyli |
| Approach | 3 Percutaneous |
| Device | Z No Device |
| Qualifier | Z No Qualifier |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
Destruction procedures in the lymphatic and hemic systems eliminate abnormal tissue in place, using heat, cold, chemicals, or other energy sources rather than physically cutting it out. In practice this most often means sclerotherapy or ablation of lymphatic malformations, cystic hygromas, or enlarged lymph nodes, where injecting or applying an agent causes the abnormal tissue to shrink and scar down.
This approach is favored when surgical removal would be difficult or risky, such as malformations located near major blood vessels or nerves, or in children where minimizing surgical trauma matters. It can also be used to manage lymphoceles that have not responded to simple drainage.
Because the tissue is destroyed rather than removed, there is nothing sent to pathology, which is a key practical difference from excisional approaches.
Anatomy & Axis Detail
Cisterna Chyli
The cisterna chyli is a small saccular dilation situated retroperitoneally near the aorta at roughly the level of the first two lumbar vertebrae, serving as the confluence point where lumbar and intestinal lymphatic trunks converge before ascending as the thoracic duct. Destruction of this structure is an uncommon procedure, generally considered only when an associated lymphatic malformation or abnormal cystic dilation is being obliterated in place using thermal or chemical ablative techniques rather than being physically excised. Its deep retroperitoneal position adjacent to the aorta and lumbar vessels makes any intervention technically demanding and typically image-guided. Coders should verify the operative note specifically documents in-place tissue destruction rather than resection or ligation of the structure.
Approach: Percutaneous
Percutaneous describes entry by needle or instrument puncture through the skin or mucous membrane to reach the site of the procedure, without cutting the tissue open or using a visualizing scope. It differs from Open in that the site itself is never exposed, and from Percutaneous Endoscopic in that no endoscope is used to see internal structures. Common examples include needle biopsies and injections.
Coding & Documentation
Coders should assign Destruction when the documentation describes obliterating tissue in place, through sclerosing agents, laser, radiofrequency, or similar means, with no specimen extracted from the body. The specific agent or energy source used should be reflected in the approach and, where applicable, the qualifier.
A common error is coding a sclerotherapy injection as Introduction of a substance rather than Destruction of the target tissue, since both involve injecting an agent but only one is aimed at eradicating the lymphatic structure itself. Reviewing physician intent and the described tissue effect, rather than just the act of injection, resolves this distinction.